- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
CRISPR Therapeutics (CRSP)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 294.50 mm | 294.50 mm | 294.50 mm | 294.50 mm | 294.50 mm | 294.50 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 44.02 mm | 47.87 mm | 28.21 mm | 25.21 mm |
| Cash used (since last report) | n/a | n/a | 189.52 mm | 206.08 mm | 121.46 mm | 108.53 mm |
| Cash remaining | n/a | n/a | 104.99 mm | 88.43 mm | 173.05 mm | 185.98 mm |
| Runway (months of cash) | n/a | n/a | 2.4 | 1.8 | 6.1 | 7.4 |
| 13F holders | Current |
|---|---|
| Total holders | 404 |
| Opened positions | 68 |
| Closed positions | 82 |
| Increased positions | 113 |
| Reduced positions | 116 |
| 13F shares | Current |
|---|---|
| Total value | 2.32 tn |
| Total shares | 79.61 mm |
| Total puts | 1.92 mm |
| Total calls | 1.55 mm |
| Total put/call ratio | 1.2 |
| Largest owners | Shares | Value |
|---|---|---|
| ARK Investment Management | 8.97 mm | $353.18 bn |
| Capital International Investors | 8.74 mm | $344.15 bn |
| VRTX Vertex Pharmaceuticals | 5.38 mm | $353.37 mm |
| T. Rowe Price Investment Management | 3.81 mm | $150.03 mm |
| GSK GSK | 3.31 mm | $278.46 mm |
| Bayer Global Investments B.V. | 2.95 mm | $154.89 mm |
| BLK BlackRock | 2.76 mm | $108.61 bn |
| CMTDF Sumitomo Mitsui Trust | 2.75 mm | $108.07 bn |
| Nikko Asset Management Americas | 2.75 mm | $108.07 bn |
| STT State Street | 2.49 mm | $98.07 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Jan 26 | Raju Prasad | Common Shares | Sell | Dispose S | No | Yes | 60.19 | 34,972 | 2.10 mm | 6,767 |
| 22 Jan 26 | Raju Prasad | Common Shares | Option exercise | Acquire M | No | No | 45.15 | 34,972 | 1.58 mm | 41,739 |
| 22 Jan 26 | Raju Prasad | Stock Option Common Shares | Option exercise | Dispose M | No | No | 45.15 | 34,972 | 1.58 mm | 41,667 |
| 22 Jan 26 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 60.23 | 60,000 | 3.61 mm | 134,201 |
| 20 Jan 26 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 52.1 | 8,567 | 446.34 k | 194,201 |
| 20 Jan 26 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 51.61 | 21,433 | 1.11 mm | 202,768 |
| 6 Jan 26 | Raju Prasad | Common Shares | Sell | Dispose S | No | Yes | 60.2134 | 5,763 | 347.01 k | 6,767 |
| 6 Jan 26 | Raju Prasad | Common Shares | Sell | Dispose S | No | Yes | 60 | 5,004 | 300.24 k | 12,530 |
| 6 Jan 26 | Raju Prasad | Common Shares | Sell | Dispose S | No | Yes | 60.1799 | 18,933 | 1.14 mm | 17,534 |
| 6 Jan 26 | Raju Prasad | Common Shares | Option exercise | Acquire M | No | No | 44.31 | 6,339 | 280.88 k | 36,467 |